Literature DB >> 22649012

Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears.

Sepehr N Tabrizi1, Matthew P Stevens, Zaheer A Khan, Conan Chow, Martin A Devitt, Suzanne M Garland.   

Abstract

PapType human papillomavirus (HPV) assay was compared to Hybrid Capture 2 (HC2), Amplicor (Amp), and Linear Array (LA) HPV tests in 894 women undergoing management for a high-grade Pap smear abnormality. The sensitivity in detection of underlying high-grade histological diagnosis by PapType was 90.3% and by HC2 was 79.8%, while by Amp and LA it was 92.4% and 91.6%, respectively. The specificities were 52.5%, 55.3%, 49.4%, and 51.7% for PapType, HC2, Amp, and LA, respectively.

Entities:  

Mesh：

Year:  2012        PMID： 22649012      PMCID： PMC3421518          DOI： 10.1128/JCM.01064-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Quality assessment for human papillomavirus testing.

Authors:  Sepehr N Tabrizi
Journal:  Sex Health       Date:  2010-09       Impact factor: 2.706

2.  Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens.

Authors:  Sarah E Tan; Suzanne M Garland; Alice R Rumbold; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

3.  Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.

Authors:  Matthew P Stevens; Elice Rudland; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors:  Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system.

Authors:  Matthew P Stevens; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Virol Methods       Date:  2007-11-08       Impact factor: 2.014

6.  Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay.

Authors:  Philippe Halfon; Dominique Benmoura; Hacene Khiri; Guillaume Penaranda; Bernard Blanc; Daniela Riggio; Maria Teresa Sandri
Journal:  J Clin Virol       Date:  2009-11-25       Impact factor: 3.168

7.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

8.  Comparison of molecular assays for detection and typing of human papillomavirus.

Authors:  Christoph Koidl; Michael Bozic; Ita Hadzisejdic; Maja Grahovac; Blazenka Grahovac; Wolfgang Kranewitter; Egon Marth; Harald H Kessler
Journal:  Am J Obstet Gynecol       Date:  2008-04-25       Impact factor: 8.661

9.  HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia.

Authors:  Matthew P Stevens; Suzanne M Garland; Jeffrey H Tan; Michael A Quinn; Rodney W Petersen; Sepehr N Tabrizi
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327
  9 in total
  4 in total

1.  Comparison of the Roche Cobas® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus.

Authors:  S Phillips; A M Cornall; D A Machalek; S M Garland; D Bateson; M Garefalakis; S N Tabrizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-13       Impact factor: 3.267

2.  Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

Authors:  Jack Cuzick; Linda Ho; George Terry; Michelle Kleeman; Michael Giddings; Janet Austin; Louise Cadman; Lesley Ashdown-Barr; Maria J Costa; Anne Szarewski
Journal:  J Clin Virol       Date:  2014-02-14       Impact factor: 3.168

Review 3.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.

Authors:  Chichao Xia; Sile Li; Teng Long; Zigui Chen; Paul K S Chan; Siaw Shi Boon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

4.  Detection of infectious organisms in archival prostate cancer tissues.

Authors:  Melissa A Yow; Sepehr N Tabrizi; Gianluca Severi; Damien M Bolton; John Pedersen; Anthony Longano; Suzanne M Garland; Melissa C Southey; Graham G Giles
Journal:  BMC Cancer       Date:  2014-08-09       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.